UK-based transformative intelligence provider Clarivate sold its Life Sciences & Healthcare Segment for $600M to US-based PE firm Altaris, reflecting investor appetite for mission-critical healthcare data assets.
Seller Name
Clarivate
Buyer Name
Altaris
Deal Value
$600M
Link
Value Type
Featured Category